These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6191393)

  • 1. [Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance].
    Feuerstein J; Revol M; Roger J; Sallou C; Truelle JL; Vercelletto P; Weber M
    Sem Hop; 1983 Apr; 59(16):1263-74. PubMed ID: 6191393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sodium valproate (Na VPa) monotherapy in childhood epilepsy ].
    Dulac O; Steru D; Rey E; Arthuis M
    Arch Fr Pediatr; 1982; 39(6):347-52. PubMed ID: 6812534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate sodium in epilepsy. A clinical trial including monitoring of drug levels.
    Mehrotra TN; Aneja GK; Arora V; Goel S; Singh VS
    J Assoc Physicians India; 1990 Apr; 38(4):277-9. PubMed ID: 2118134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scope and use of valproate in epilepsy.
    Penry JK; Dean JC
    J Clin Psychiatry; 1989 Mar; 50 Suppl():17-22. PubMed ID: 2494154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine].
    Loiseau P; Cohadon S; Jogeix M; Legroux M; Dartigues JF
    Rev Neurol (Paris); 1984; 140(6-7):434-7. PubMed ID: 6431586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of sodium valproate in the treatment of partial epilepsy].
    Chadwick D
    Praxis (Bern 1994); 1994 Oct; 83(40):1140-3. PubMed ID: 7939086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of age, body weight and dose on sodium valproate plasma concentrations in children with epilepsy].
    Jiang Z; Zhang J; Liao HM; Tang JW; Peng QL
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):325-8. PubMed ID: 18554460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G; Arhan E; Unal B; Ozaydin E; Guven A; Sayli TR
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
    Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
    Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advantages of a single daily dose of sodium valproate in the child].
    Giroud M; Couillault G; Gouyon JB; Dauvergne M; Fantino M; Nivelon JL
    Arch Fr Pediatr; 1989 Apr; 46(4):255-6. PubMed ID: 2502101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
    Klotz U; Schweizer C
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.